20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
CLEVIDIPINE NANOPARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#3602Method for inactivating zika virus and for determining the completeness of inactivation
#3603Transdermal Optogenetic Peripheral Nerve Stimulation
#3604Use of amisulpride as an anti-emetic
#3605COMPOSITIONS FOR TREATMENT OF SPINAL CORD INJURY, METHODS AND USES THEREOF
#3606Fractionated radiotherapy and chemotherapy with an oxygen therapeutic
#3607Treating Pulmonary Inflammatory Disease Associated With Covid-19 By Administering Resiniferatoxin
#3608Cannabinoid receptor type 2 (CB2) modulators and uses thereof
#3609COMPOSITIONS AND METHODS FOR EMERGENCY RESCUE
#3610LINEZOLID FORMULATIONS
#3611LIQUID PREPARATIONS OF AMINES AND ORGANIC ACIDS STABILIZED BY SALTS
#3612Reconstituted HDL formulation
#3613COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION
#3614NEW BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM
#3615PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES
#3616NEUROACTIVE STEROID SOLUTIONS AND THEIR METHODS OF USE
#3617CARDIOSPHERE-DERIVED CELL (CDC) THERAPY FOR THE TREATMENT OF VIRAL INFECTIONS
#3618DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION
#3619Treatment of immune disorders
#3620C-type natriuretic peptide variants to treat skeletal dysplasia in children
#3621TRICYCLIC COMPOUNDS, PREPARATION METHOD AND MEDICAL USE THEREOF
#3622INJECTABLE EPINEPHRINE FORMULATIONS DEMONSTRATING ACTIVE PHARMACEUTICAL INGREDIENT (API) RETENTION OVER TIME
#3623O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#3624Single-dose, ready-to-use injectable formulations
#3625POLYMER LUNG SURFACTANTS
#3626HETEROCLITIC CANCER VACCINES
#3627HA-PACLITAXEL CONJUGATE FOR TREATMENT OF MESOTHELIOMA
#3628Succinylcholine Chloride Prefilled Syringe
#3629Solid Deep Eutectic Solvent Formulation Platform
#3630LONG-ACTING APOMORPHINE FORMULATIONS AND INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
#3631LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION
#3632TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTION
#3633COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR AND A BCL-2 INHIBITOR
#3634LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO STABILIZE INTO PHARMACEUTICALLY RELEVANT DRUG PRODUCTS
#3635PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#3636Methods for treating multidrug resistant breast cancer
#3637HYDROPHILIC ANTIBODY-DRUG CONJUGATES
#3638Succinylcholine chloride prefilled syringe
#3639Rifabutin treatment methods, uses, and compositions
#3640Methods and Compositions for Treatment of Disorders and Diseases Involving RDH12
#3641ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
#3642FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIES
#3643Method of treating cancer using selective estrogen receptor modulators
#3644Stabilized liquid and lyophilized ADAMTS13 formulations
#3645GLYCOLIPID COMPOSITIONS AND METHODS OF USE
#3646TREATMENT OF PAIN BY ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS
#3647METHODS FOR DOSE INITIATION OF ARIPIPRAZOLE TREATMENTS
#3648Methods for regulating free fatty acid flux using fat specific protein 27 (FSP27) compositions
#3649PARENTERAL NUTRITION SOLUTION COMPRISING A SELENIUM SOURCE
#3650HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES
#3651MULTI CHAMBER SYRINGE UNIT AND METHOD OF PREPARING A MULTI CHAMBER SYRINGE
#3652Rotavirus vaccines
#3653Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
#365417α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors
#3655TREATMENT OF HYPERINFLAMMATORY SYNDROME
#3656Spiro-lactam NMDA modulators and methods of using same
#3657BROAD-SPECTRUM CARBAPENEMS
#3658USE OF HAEMOGLOBIN FROM ANNELIDS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME
#3659PEPTIDE ANALOGS AND USE OF SAME IN TREATING DISEASES, DISORDERS OR CONDITIONS ASSOCIATED WITH MUTANT P53 PROTEIN
#3660PEPTIDOMIMETIC MACROCYCLES AND FORMULATIONS THEREOF
#3661COMPOSITIONS AND METHODS FOR THE TREATMENT OF TOXIC GAS EXPOSURE
#3662Aqueous Formulation of Erythropoiesis Stimulating Protein Stabilised by Antioxidants for Parenteral Administration
#3663METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#3664Products Derived from Amniotic Fluid and Methods of Use
#3665TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS
#3666Therapeutic Methods And Uses Thereof
#3667AGENTS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOMA
#3668Prevention of progressive heart failure
#3669PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION
#3670PHARMACEUTICAL COMPOSITION
#3671HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE
#3672NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
#3673A PHARMACEUTICAL COMBINATION OF AN ARTEMISININ COMPOUND, 5-AMINOLEVULINIC ACID OR METHYL-5-AMINOLEVULINIC ACID AND A CHEMOTHERAPEUTIC AGENT
#3674CEPHALOSPORIN ANTIBACTERIAL COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF
#3675PTH prodrugs
#3676Method for optimizing 5-hydroxytryptamine function in the brain for therapeutic purposes
#3677COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
#3678REGIMENS FOR TREATING HIV INFECTIONS AND AIDS
#3679Method and apparatus for sorting heterogeneous material
#3680OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR
#3681PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
#3682PHARMACEUTICAL COMPOSITION COMPRISING 3-BETA-HYDROXY-5-ALPHA-PREGNAN-20-ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES
#3683METHOD OF INJECTING OCTREOTIDE ACETATE INTO THE BODY
#3684CNP PRODRUGS
#3685METHODS FOR TREATING COLORECTAL AND METASTATIC COLORECTAL CANCERS
#3686NOVEL POLYINOSINIC - POLYCYTIDYLIC ACID COMPOSITIONS AND METHODS OF MAKING SAME
#3687PROCESSES OF MAKING 3-FLUORO-5-(((1S,2aR)-1,3,3,4,4-PENTAFLUORO-2a-HYDROXY-2,2a,3,4-TETRAHYDRO-1H-CYCLOPENTA[CD]INDEN-7-YL)OXY)-BENZONITRILE AND POLYMORPHS THEREOF
#3688Formulations of Bendamustine
#3689ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
#3690Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
#3691Formulations of bendamustine
#3692MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE
#3693METHODS AND COMPOSITIONS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER
#3694TRACE ELEMENT SOLUTION
#3695RESPIRATORY SYNCYTIAL VIRUS VACCINE
#3696TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES
#3697COMPOSITION AND METHOD TO PREPARE LONG-ACTING INJECTABLE SUSPENSION CONTAINING MULTIPLE CANCER DRUGS
#3698INHIBITORS OF MICROBIALLY INDUCED AMYLOID
#3699THERAPEUTIC SYSTEM FOR THE TOPIC, TRANSDERMAL AND TRANSCUTANEOUS APPLICATION OF CARBON MONOXIDE
#3700IL-1 Binding Proteins
#3701CANINE BLOOD PLATELET PREPARATIONS
#3702Methods and reagents for treating diabetes
#3703Treatment of epithelial cysts by intracystic injection of antineoplastic particles
#3704Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
#3705EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
#3706Methods for modulating an immune response
#3707INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#3708METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
#3709USE OF CDK9 INHIBITORS TO REDUCE CARTILAGE DEGRADATION
#3710ULTRAFINE NANOPARTICLES COMPRISING A FUNCTIONALIZED POLYORGANOSILOXANE MATRIX AND INCLUDING METAL COMPLEXES; METHOD FOR OBTAINING SAME AND USES THEREOF IN MEDICAL IMAGING AND/OR THERAPY
#3711METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY
#3712METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#3713Stabilizing Camptothecin Pharmaceutical Compositions
#3714COMPOSITION AND METHOD OF mRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION
#3715CONTROLLED RELEASE SYSTEM FOR PULMONARY DELIVERY OF SURFACTANT PROTEIN D
#3716INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATION
#3717MEDICATION INFUSION COMPONENTS AND SYSTEMS
#3718Methocarbamol compositions and related methods
#3719Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
#3720AN ORAL PHARMACEUTICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASE AND THE USE THEREOF
#3721PHARMACEUTICAL FORMULATION OF NON-ACTIVATED POLYPEPTIDE TRP
#3722DOSAGE REGIME
#3723INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#3724HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS
#3725PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#3726Dosing regimens associated with extended release paliperidone injectable formulations
#3727Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane
#3728USE OF COMPOSITION IN TREATING ATHEROSCLEROSIS
#3729METHODS OF INCREASING PROGENITOR CELL PRODUCTION
#3730USE OF ANTI-FAM19A1 ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES
#3731Hazardous Agent Injection System
#3732METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER
#3733BORTEZOMIB COMPOSITIONS
#3734INDUCING PRODUCTION OF ANTI-OLIGOMANNOSE ANTIBODIES
#3735INHIBITORS OF MICROBIALLY INDUCED AMYLOID
#3736MEDICAL USE OF ICARITIN
#3737SYSTEMS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT BY DIRECT INJECTION OF A TARGETED POPULATION OF CELLS
#3738MATERIALS AND METHODS FOR THE TREATMENT OF GAUCHER DISEASE
#3739PHARMACEUTICAL COMPOSITION COMPRISING BISPECIFIC ANTIBODY CONSTRUCTS
#3740METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS
#3741Carbohydrate crosslinker
#3742[6R]-MTHF IN 5-FU BASED CHEMOTHERAPY OF LEFT-SIDED COLORECTAL CANCER
#3743Therapy for polyglutamine (polyQ) diseases
#3744Rescue treatment of post operative nausea and vomiting
#3745EPINEPHRINE FORMULATIONS
#3746INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#3747Treating IgE-mediated allergic diseases
#3748RESTORATION OF T CELL ACTIVITY VIA THE CD39/CD73 AXIS
#3749NANOPARTICLE COMPOSITIONS
#3750COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER
#3751TREATMENT OF CANCER
#3752MINOCYCLINE COMPOUNDS FOR BIODEFENSE
#3753RESPONSIVE ELASTIC POLYMERS AND METHODS OF MAKING AND USING SAME
#3754PYRROLIDINE DERIVATIVES AS OXYTOCIN/VASOPRESSIN V1A RECEPTORS ANTAGONISTS
#3755NON-NATURALLY OCCURRING VESICLES COMPRISING A CHIMERIC VESICLE LOCALIZATION MOIETY, METHODS OF MAKING AND USES THEREOF
#3756NEONATAL FC RECEPTOR BINDING AFFIMERS
#3757FIBROBLAST GROWTH FACTOR 1 (FGF1) MUTANT PROTEINS THAT SELECTIVELY ACTIVATE FGFR1B TO REDUCE BLOOD GLUCOSE
#3758[6R]-MTHF IN 5-FU BASED CHEMOTHERAPY OF RIGHT-SIDED COLORECTAL CANCER
#3759PHARMACEUTICAL COMPOSITION COMPRISING SUSTAINED-RELEASE MICROSPHERES INCLUDING GLP-1 ANALOGUE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#3760COMBINED TREATMENT REGIMEN OF ANESTHESIA/SEDATION WITH ADMINISTRATION OF PSYCHEDELIC DRUGS ASSOCIATED WITH REDUCTION IN NEUROPSYCHIATRIC ILLNESS
#3761PHARMACEUTICAL COMPOSITION FOR INHIBITING INFLAMMATORY RESPONSE COMPRISING HYDROXYUREA
#3762Bortezomib compositions
#3763DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
#3764Hydroxypropyl beta-cyclodextrin compositions and methods
#3765COMPOSITIONS AND METHODS FOR NALOXONE DELIVERY
#3766Therapeutic uses for sodium thiosulfate and formulations
#3767PHARMACEUTICAL COMBINATION FOR TREATING TUMORS AND APPLICATION THEREOF
#3768Therapeutic uses for sodium thiosulfate formulations
#3769DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR
#3770GLP-1 COMPOSITIONS AND USES THEREOF
#3771Vasodilators for treatment of heart failure
#3772RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
#3773DENDRIMER COMPOSITIONS AND THEIR USE IN TREATMENT OF DISEASES OF THE EYE
#3774METHODS FOR THE TREATMENT OF HUNTER SYNDROME
#3775COMBINATION CONTAINING A DUOCARMYCIN DERIVATIVE-COMPRISING ANTIBODY-DRUG CONJUGATE AND THIOSULFATE
#3776Subcutaneous HER2 antibody formulations
#3777INTERMITTENT DOSING OF MDM2 INHIBITOR
#3778BACTERIOPHAGE COMPOSITIONS FOR TREATING STAPHYLOCOCCUS INFECTION
#3779Crystalline forms of tenofovir alafenamide
#3780PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS
#3781BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#3782Early intervention methods to prevent or ameliorate toxicity
#3783PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS
#3784CALPAIN-2 INHIBITOR COMPOUNDS AND METHODS OF TREATMENT
#3785Stable pharmaceutical compositions of succinylcholine chloride
#3786DRUG FOR TREATING CORONAVIRAL AND RETROVIRAL INFECTIONS AND HEPATITIS C
#3787METHODS OF TREATING GLIOBLASTOMA MULTIFORME USING COMBINATION THERAPY
#3788ISOLATION, ENRICHMENT AND EXPANSION OF CONE PROGENITOR CELLS AND USES THEREOF
#3789Lipidated immune response modifier compound compositions, formulations, and methods
#3790SMALL MOLECULE INHIBITORS OF VOLTAGE-GATED SODIUM CHANNEL 1.7 AND METHODS OF USING SAME
#3791ANTIBIOTICS
#3792ENGINEERED METAL NANOPARTICLES AND METHODS THEREOF
#3793USE OF EARLY APOPTOTIC CELLS FOR TREATING COVID-19
#3794COMBINATION OF AN LSD-1 INHIBITOR AND NIVOLUMAB FOR USE IN TREATING SCLC OR SQNSCLC
#3795COMPOSITIONS FOR THE TREATMENT OF ANGIOLIPOMA
#3796Fused ring compounds
#3797NOVEL NICOTINE-BINDING ANTIBODIES
#3798Methods For Treating Pancreatic Cancer Using Combination Therapies
#3799TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS
#3800Ergoline analogues
#3801Drug mixing and delivery system and method
#3802Composition for ameliorating psoriasis comprising cimicifugolide a as active ingredient
#3803COMPOSITIONS AND METHODS OF TREATING CARDIAC HYPERTROPHY AND HEART FAILURE
#3804CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY
#3805Perfusion dosage form
#3806DEFIBROTIDE TREATMENT FOR THE PREVENTION OF ORGAN REJECTION AND INJURY
#3807STABLE PHARMACEUTICAL COMPOSITIONS OF SUCCINYLCHOLINE CHLORIDE
#3808NOVEL METHOD OF ENHANCED DRUG DELIVERY TO THE NERVOUS SYSTEM
#3809NOVEL POLYINOSINIC - POLYCYTIDYLIC ACID COMPOSITIONS
#3810PDAC TREATMENT REGIMEN
#3811Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
#3812SHEAR-THINNING COMPOSITIONS AS AN INTRAVASCULAR EMBOLIC AGENT
#3813INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#3814COMBINATION THERAPIES OF PREDNISONE AND URICASE MOLECULES AND USES THEREOF
#3815METHODS FOR TREATING PATIENTS HAVING SINUSOIDAL OBSTRUCTION SYNDROME
#3816METHOD
#3817Iron compositions and methods of making and using them
#3818Immunoglobulin Preparation and Storage System for an Immunoglobulin Preparation
#3819METHODS FOR TREATMENT OF MASSETER MUSCLE HYPERTROPHY
#3820AMANTADINE HYDROCHLORIDE FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY
#3821SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
#3822PHARMACEUTICAL FORMULATIONS
#3823Methods of treating cancer
#3824HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT FIBROSIS
#3825TREATMENT OF CONNECTIVE TISSUE INJURIES
#3826PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION
#3827FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF USING THE SAME
#3828HYDROGEL-BASED BIOLOGICAL DELIVERY VEHICLE
#3829METHODS FOR TREATMENT OF MASSETER MUSCLE HYPERTROPHY
#3830SENSOR FOR DETECTING THE PROXIMITY OF AN IEEE 802.11 PROTOCOL CONNECTABLE DEVICE
#3831Methods of treatment of arthritis and/or psoriasis with pharmaceutical formulations of etanercept
#3832BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#3833NANOPARTICLES ENCAPSULATING SMALL MOLECULES
#3834Compounds for treating TNBC
#3835USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST CANCER
#3836Pharmaceutical compositions containing mixed polymeric micelles
#3837METHODS OF TREATING AND PREVENTING ENGRAFTMENT ARRHYTHMIAS
#3838ACTIVATION OF NEUROPEPTIDE RECEPTORS ON PLASMACYTOID DENDRITIC CELLS TO TREAT OR PREVENT OCULAR DISEASES ASSOCIATED WITH NEOVASCULARIZATION AND INFLAMMATION
#3839BUPRENORPHINE DOSING REGIMENS
#3840METHODS AND COMPOSITIONS FOR TREATING CANNABINOID OVERDOSE WITH A CANNABINOID RECEPTOR ANTAGONIST
#3841Modified U6 promoter system for tissue specific expression
#3842TREATMENT OF CIRRHOSIS USING BOTULINUM TOXIN
#3843Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations
#3844INJECTABLE EPINEPHRINE FORMULATIONS DEMONSTRATING STABILITY OVER TIME
#3845Coronavirus vaccine
#3846Combination therapy for cancer treatment
#3847TREATMENT OF ATOPIC DERMATITIS WITH ANTI-TSLP ANTIBODY
#3848PROSTATE TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS
#3849Methods of use of emulsion formulations of an NK-1 receptor antagonist
#3850TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#3851Insulin-Fc fusion proteins and methods of use to treat cancer
#3852METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION
#3853PHARMACEUTICAL FORMULATIONS AND DOSAGE REGIMENS FOR FACTOR XI/XIA ANTIBODIES
#3854Sigma-1 receptor agonist systolic blood pressure therapy
#3855Natural Killer Cells for Treatment of Coronavirus Infection
#3856TREATMENT OF VASOPRESSOR-INDUCED DIGITAL ISCHEMIA WITH BOTULINUM TOXIN A
#3857MATRIX BOUND VESICLES (MBV) FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
#3858TREATMENT OF ASTHMA USING BOTULINUM TOXIN
#3859Methods of Treating Alzheimer's Disease
#3860Iron compositions and methods of making and using the same
#3861CONCENTRATED SODIUM VALPROATE FOR RAPID DELIVERY
#3862Hydroxypropyl beta-cyclodextrin compositions and methods
#3863STABILIZATION OF SELENITE IN A NUTRITIONAL SOLUTION BY DISSOLVED OXYGEN
#3864COMPOSITIONS AND FORMULATIONS INCLUDING CABAZITAXEL AND HUMAN SERUM ALBUMIN
#3865Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer
#3866COMPOSITIONS COMPRISING EPHEDRINE OR AN EPHEDRINE SALT AND METHODS OF MAKING AND USING SAME
#3867Rifabutin treatment methods, uses, and compositions
#3868POXVIRAL-BASED VACCINE AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 AND METHODS USING THE SAME
#3869EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#3870METHODS FOR PREVENTING AND REVERSING OPIOID ANALGESIC TOLERANCE IN SUBJECTS WITH CHRONIC PAIN
#3871Pharmaceutical composition and use thereof
#3872Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cell tumors
#3873SUBCUTANEOUS DELIVERY OF MESSENGER RNA
#3874COMPOSITION FOR INTRAPERICARDIAL INJECTION COMPRISING STEM CELLS AND USE THEREOF
#3875Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#3876Poly(beta-amino esters) and uses thereof
#3877Liquid pharmaceutical composition
#3878METHOD FOR TREATING OR ALLEVIATING AUTOIMMUNE-RELATED DISEASES
#3879MEDICAL DEVICE AND METHOD FOR TREATMENT OF OSTEOARTHRITIS
#3880Methods for ameliorating infusion reactions
#3881INITIATING NEUROTOXIN TREATMENTS
#3882THERAPEUTIC APPLICATIONS OF ARTIFICIAL CEREBROSPINAL FLUID AND TOOLS PROVIDED THEREFOR
#3883NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS
#3884INJECTABLE CONTROLLED-RELEASE FORMULATIONS OF PROGESTOGEN DRUGS
#3885RECOMBINANT ADENO-ASSOCIATED VIRUS FOR DELIVERY OF KH902 (CONBERCEPT) AND USES THEREOF
#3886Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors
#3887GAS-FILLED MICROVESICLES FOR THERAPEUTIC USE
#3888PHARMACEUTICAL COMPOSITION CONTAINING A SURFACTANT AND NATURAL PLANT EXTRACTS FOR PREVENTING AND TREATING CORONAVIRUS
#3889Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
#3890METHODS AND COMPOSITIONS FOR CANCER IMMUNOTHERAPY
#3891METHODS AND COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME
#3892STABLE ANTI-PD1 ANTIBODY PHARMACEUTICAL FORMULATIONS
#3893Compositions and methods for reducing muscle contraction
#3894NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM
#3895Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#3896COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASE
#3897COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION
#3898METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA
#3899COMPOSITIONS FOR PREVENTION AND TREATMENT OF SYMPTOMS ASSOCIATED WITH ALCOHOL CONSUMPTION
#3900PROCESS FOR KIDNEY CELL MANUFACTURE AND TREATMENT